Keratinocyte Proliferation Pathway Suppression (KPPS)

Keratinocyte proliferation pathway suppression refers to the inhibition of cellular signaling mechanisms that drive the growth and division of keratinocytes, the predominant cell type in the epidermis. This process is relevant in conditions where excessive keratinocyte proliferation contributes to disease, such as psoriasis or skin cancer. Key pathways involved include mTOR, EGF-EGFR-ERK, IL-17R-TRAF4-ERK5, and KGF-induced cell cycle progression. Targeting these pathways offers potential strategies for managing diseases characterized by excessive or abnormal skin cell growth while preserving normal wound healing functions.

Other names

Inhibition of Keratinocyte ProliferationSuppression of Epidermal GrowthKeratinocyte Hyperproliferation Control

Inhibition of cellular signaling mechanisms that drive the growth and division of keratinocytes, including mTOR pathway, EGF–EGFR–ERK signaling, IL-17R–TRAF4–ERK5 axis, and KGF-induced cell cycle progression.